Molecular insights into recognition of GUCY2C by T-cell engaging bispecific antibody anti-GUCY2CxCD3
Abstract The intestinal epithelial receptor Guanylyl Cyclase C (GUCY2C) is a tumor-associated cell surface antigen expressed across gastrointestinal malignancies that can serve as an efficacious target for colorectal cancer immunotherapy. Here, we describe a yeast surface-display approach combined w...
Glavni autori: | Pragya Rampuria, Lidia Mosyak, Adam R. Root, Kristine Svenson, Michael J. Agostino, Edward R. LaVallie |
---|---|
Format: | Članak |
Jezik: | English |
Izdano: |
Nature Portfolio
2023-08-01
|
Serija: | Scientific Reports |
Online pristup: | https://doi.org/10.1038/s41598-023-40467-0 |
Slični predmeti
-
Discovery and optimization of a novel anti-GUCY2c x CD3 bispecific antibody for the treatment of solid tumors
od: Adam R. Root, i dr.
Izdano: (2021-01-01) -
Intestinal neuropod cell GUCY2C regulates visceral pain
od: Joshua R. Barton, i dr.
Izdano: (2023-08-01) -
CD8α Structural Domains Enhance GUCY2C CAR-T Cell Efficacy
od: Trevor R. Baybutt, i dr.
Izdano: (2024-12-01) -
GUCY2C signaling limits dopaminergic neuron vulnerability to toxic insults
od: Lara Cheslow, i dr.
Izdano: (2024-04-01) -
308 GUCY2C-directed CAR-T cell therapy for upper GI cancers
od: Robert Carlson, i dr.
Izdano: (2023-11-01)